Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
12.79
-0.11 (-0.85%)
Jul 3, 2025, 1:00 PM - Market closed
Core Laboratories Stock Forecast
Stock Price Forecast
The 4 analysts that cover Core Laboratories stock have a consensus rating of "Hold" and an average price target of $15, which forecasts a 17.28% increase in the stock price over the next year. The lowest target is $13 and the highest is $17.
Price Target: $15 (+17.28%)
Analyst Consensus: Hold
* Price targets were last updated on May 13, 2025.
Analyst Ratings
The average analyst rating for Core Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 3 | 3 | 3 | 3 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Hold Maintains $16 → $13 | Hold | Maintains | $16 → $13 | +1.64% | May 13, 2025 |
Stifel | Stifel | Hold Maintains $19 → $15 | Hold | Maintains | $19 → $15 | +17.28% | Apr 15, 2025 |
Citigroup | Citigroup | Strong Sell → Hold Upgrades $15 → $16 | Strong Sell → Hold | Upgrades | $15 → $16 | +25.10% | Mar 12, 2025 |
Citigroup | Citigroup | Strong Sell Maintains $14 → $15 | Strong Sell | Maintains | $14 → $15 | +17.28% | Feb 20, 2025 |
Citigroup | Citigroup | Strong Sell Maintains $15 → $14 | Strong Sell | Maintains | $15 → $14 | +9.46% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
515.90M
from 523.85M
Decreased by -1.52%
Revenue Next Year
530.97M
from 515.90M
Increased by 2.92%
EPS This Year
0.78
from 0.66
Increased by 17.45%
EPS Next Year
0.82
from 0.78
Increased by 6.27%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 544.8M | 579.9M | 623.7M |
Avg | 515.9M | 531.0M | 599.9M |
Low | 491.9M | 489.0M | 582.1M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 4.0% | 12.4% | 17.5% |
Avg | -1.5% | 2.9% | 13.0% |
Low | -6.1% | -5.2% | 9.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.90 | 0.97 | 1.19 |
Avg | 0.78 | 0.82 | 1.14 |
Low | 0.68 | 0.69 | 1.11 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 36.8% | 24.6% | 44.0% |
Avg | 17.5% | 6.3% | 38.5% |
Low | 2.5% | -11.1% | 34.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.